MSAM
CLVS

Moloney Securities Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Moloney Securities Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,000
Closed -$70K – 335
2020
Q1 		$70K Buy
+11,000
New +$88.2K 0.03% 267
2019
Q4 		– Sell
-60,000
Closed -$236K – 378
2019
Q3 		$236K Buy
+60,000
New +$485K 0.08% 272

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Moloney Securities Asset Management's CLVS Position: Q2 2020 in Review

Moloney Securities Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 11,000 shares — an estimated $70K sold.

Moloney Securities Asset Management first reported a position in CLVS in Q3 2019 and held it in 2 quarters. The position peaked at $236K in Q3 2019. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Moloney Securities Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Moloney Securities Asset Management sold 11,000 Clovis Oncology, Inc. shares in Q2 2020, an estimated $70K.
  • Moloney Securities Asset Management first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 2 quarters.
  • Moloney Securities Asset Management's Clovis Oncology, Inc. position peaked at $236K in Q3 2019.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Moloney Securities Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.